# A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2)

> **NCT06128226** · — · RECRUITING · sponsor: **Nadir Hastalıkları Araştırma Derneği** · enrollment: 750 (estimated)

## Conditions studied

- Neuronal Ceroid Lipofuxinosis Type2 (CLN2)

## Interventions

- **GENETIC:** Blood Sampling

## Key facts

- **NCT ID:** NCT06128226
- **Lead sponsor:** Nadir Hastalıkları Araştırma Derneği
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-06
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06128226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06128226, "A Multicenter Selective Screening Study to Investigate the Frequency of Neuronal Ceroid Lipofuxinosis Type 2 (CLN2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06128226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*